Page 309 - Read Online

Kohla et al. Transforming growth factor β1 in HCC

2013;30:673. 17. Flisiak R, Prokopovicz D. Transforming growth factor beta 1 as a
14. Pérez-Gómez E, Castillo G, Santibanez JF, López-Novoa JM, surrogate marker of hepatic dysfunction in chronic liver disease. Clin
Bernabéu C, Quintanella M . The role of the TGF-β coreceptor Chem Lab Med 2000;38:1129-31.
endoglin in cancer. Sci World J 2010;10:2367- 84. 18. Mayoral R, Valverde MA, Izquirdo LC, Gonzàles-Rodríguez A,
15. Shariat SF, Kim JH, Andrew B, Kattan MW, Wheeler TM, Kim IY, Boscà L, Martín-Sanz P. Impairment of transforming growth factor
Lerner SP, Slawin KM. Preoperative plasma level of transforming beta signaling in Caveolin-1 deficient hepatocytes: role in liver
growth factor b strongly predict patients outcome in bladder regeneration. J Biol Chem 2010;285:3633-42.
carcinoma. Cancer 2001;92:2985- 92. 19. Massague J. TGF-b signaling in context. Nat Rev Mol Cell Biol
16. Hussein M, Ibrahim AA, Khattab NF, El-Fouly RF, El-Fouly NF. 2012;13:616-30.
Serum transforming growth factor beta 1 in hepatitis C virus related 20. Gupta S, Bent S, Kohlwes J. Test characteristics of alpha-fetoprotein
chronic liver disease and hepatocellular carcinoma patients. Med J for detecting hepatocellular carcinoma in patients with hepatitis C. A
Cairo Uni 2010;78:279-86. systematic review and critical analysis. Ann Intern Med 2003;139:46-50.

Hepatoma Research ¦ Volume 3 ¦ December 12, 2017 301